CVS
52
2
NRG
45
3
NI
75
3
BWA
55
-5
KO
47
3
EXR
44
4
GE
55
-5
VIX
38
-3
BSX
42
2
YUM
58
2
PSA
35
15
CNX
48
4
PSX
70
-4
O
48
-14
PGR
40
3
WM
80
6
MS
61
2
MAT
30
-2
D
58
5
A
37
3
CVS
52
2
NRG
45
3
NI
75
3
BWA
55
-5
KO
47
3
EXR
44
4
GE
55
-5
VIX
38
-3
BSX
42
2
YUM
58
2
PSA
35
15
CNX
48
4
PSX
70
-4
O
48
-14
PGR
40
3
WM
80
6
MS
61
2
MAT
30
-2
D
58
5
A
37
3
Financhill
Back

AnaptysBio, Inc. 10K Form

Sell
47

ANAB
AnaptysBio, Inc.

Last Price:
$57.92
Seasonality Move:
5.3%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2023-11-02 10Q ANAB/AnaptysBio, Inc. Quarterly
2023-08-07 10Q ANAB/AnaptysBio, Inc. Quarterly
2023-05-11 10Q ANAB/AnaptysBio, Inc. Quarterly
2022-11-08 10Q ANAB/AnaptysBio, Inc. Quarterly
2022-08-08 10Q ANAB/AnaptysBio, Inc. Quarterly
2022-05-04 10Q ANAB/AnaptysBio, Inc. Quarterly

Receive ANAB News And Ratings

See the #1 stock for the next 7 days that we like better than ANAB

ANAB Financial Statistics

Sales & Book Value

Annual Sales: $234.6M
Cash Flow: $98M
Price / Cash Flow: 89.95
Annual Sales: $1.33
Price / Book: 45.5

Profitability

EPS (TTM): -0.52060
Net Income (TTM): $-13.2M
Gross Margin: $232.2M
Return on Equity: -97.37%
Return on Assets: -3.38%

AnaptysBio, Inc. Earnings Forecast

Key AnaptysBio, Inc. Financial Ratios

  • The Gross Profit Margin over the past 13 years for ANAB is 98.97%.
  • The Selling, General & Administrative Expenses for ANAB have been equal to 21.63% of Gross Profit Margin.
  • The Research & Development expenses have been 57.72% of Revenue.
  • The Net Earning history of ANAB is -5.64% of Total Revenues.
  • Per Share Earnings over the last 13 years have been positive in 5 years.

AnaptysBio, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ANAB
CUSIP: 032724
Website: anaptysbio.com

Debt

Debt-to-Equity Ratio: 7.81
Current Ratio: 9.07
Quick Ratio: 8.94

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ANAB Technical Analysis vs Fundamental Analysis

Sell
47
AnaptysBio, Inc. (ANAB) is a Sell

Is AnaptysBio, Inc. a Buy or a Sell?

  • AnaptysBio, Inc. stock is rated a Sell
    The current AnaptysBio, Inc. [ANAB] share price is $57.68. The Score for ANAB is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.